Each year, a large and diverse group of organizations provide annual sponsorship to help the Tufts CSDD carry out its mission. Sponsorship funding supports research activity including longitudinal studies; faculty lectures and presentations; faculty and staff participation in meetings with government agencies, academic institutions, policymakers, foundations, professional societies, and associations; manuscript preparation and submission; and center internships and exchange programs.

 

Benefits of Joining the Tufts CSDD Circle of Supporters (CoS)

  • Participate in our Research Priority Advisory Council meetings—2-3 virtual meetings per year—to help us set up our annual research agenda, share your insights, identify specific industry areas of focus, and review and discuss the implications of Tufts CSDD studies.

  • Advance notices and priority invitations to participate at the special CoS member rate in Tufts CSDD’s research studies, recurrent longitudinal studies, and/or working group studies.

  • Receive special CoS member rates on Tufts CSDD’s Impact Report bi-monthly publication (single or multi-reader subscription) and Professional Development courses, workshops, and forums.

  • Opportunity to request ad-hoc analysis and facilitated discussions with Tufts CSDD faculty and staff.

  • Receive the Tufts CSDD monthly Insider digital newsletter providing key updates on research projects, collaborations, publications, and more. Additionally, receive a special CoS digital newsletter providing specific updates for CoS members only.

  • Opportunity to participate in developing a white paper or article on key industry topics—non-promotional—that aligns with Tufts CSDD's research and data-driven insights.

  • Receive periodic public announcements as a Tufts CSDD CoS member on social media,
    bi-monthly Insider digital newsletter, and acknowledgment on Tufts CSDD’s website.

Organizations that have recently provided center sponsorship and research grant funding.


The challenges of developing pharmaceutical innovations are intensifying as R&D complexity, costs, customization, and fragmentation increase. All stakeholders involved—pharmaceutical and biotechnology companies, regulators, policymakers, public and private investigative sites and site networks, technology companies, investors, and contract service providers—need credible, objective, empirical data and actionable insights.

The work of Tufts CSDD has never been more important or relevant.
  • AdobeStock_302947983
  • AdobeStock_610212747
  • AdobeStock_735506859